Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C28H45NO5S |
Molecular Weight | 507.726 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 10 / 11 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C(=O)CC[C@]13CC[C@@H](C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CS[C@@H]4CC[C@@H](N)C[C@H]4O
InChI
InChIKey=KPVIXBKIJXZQJX-CSOZIWFHSA-N
InChI=1S/C28H45NO5S/c1-6-26(4)14-22(34-23(32)15-35-21-8-7-18(29)13-20(21)31)27(5)16(2)9-11-28(17(3)25(26)33)12-10-19(30)24(27)28/h6,16-18,20-22,24-25,31,33H,1,7-15,29H2,2-5H3/t16?,17-,18+,20+,21+,22+,24-,25-,26+,27-,28-/m0/s1
Molecular Formula | C28H45NO5S |
Molecular Weight | 507.726 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 11 / 11 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:47:05 UTC 2023
by
admin
on
Sat Dec 16 09:47:05 UTC 2023
|
Record UNII |
21904A5386
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2198944
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY | |||
|
m12169
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY | |||
|
CHEMBL3291398
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY | |||
|
9849
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY | |||
|
21904A5386
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY | |||
|
Lefamulin
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY | |||
|
5348
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY | |||
|
100000176088
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY | |||
|
Lefamulin
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY | |||
|
21904A5386
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY | |||
|
C166531
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY | |||
|
DB12825
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY | |||
|
1061337-51-6
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY | |||
|
CD-31
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY | |||
|
58076382
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY | |||
|
DTXSID101027896
Created by
admin on Sat Dec 16 09:47:06 UTC 2023 , Edited by admin on Sat Dec 16 09:47:06 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR | |||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
EXCRETED UNCHANGED |
Following IV administration
AMOUNT EXCRETED
URINE
|
||
|
SALT/SOLVATE -> PARENT | |||
|
BINDER->LIGAND |
BINDING
|
||
|
EXCRETED UNCHANGED |
Following IV administration
AMOUNT EXCRETED
FECAL
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||